Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford is to take part in three new government-funded projects designed to help universities collaborate with each other, and with external organisations, to boost research commercialisation.

None

Image courtesy of Shutterstock

Healthy ageing, the internet of things, and commercialisation in the social sciences are the three themes with involvement from Oxford academics. Oxford is leading the programme on healthy ageing, is a partner in the Sheffield University-led internet of things project, and will also participate in the social sciences initiative led by LSE.

The projects are funded via Research England (formerly the Higher Education Funding Council for England) through its Connecting Capability Fund (CCF). This £100m fund supports university collaboration in research commercialisation with the aims of sharing good practice across the higher education sector, forging external technological, industrial and regional partnerships, and helping deliver the government's industrial strategy priorities.

Oxford recently launched its 150th spinout company based on University research. In 2018 alone, six new companies have been formed and more than £150m has been raised in external investment.

Professor Chas Bountra of Oxford's Nuffield Department of Clinical Medicine is leading the healthy ageing programme, titled UK SPINE KE and also involving Birmingham and Dundee universities. Announced last autumn in the first wave of CCF awards, the £4.82m project will establish a UK-wide network across universities, businesses and the NHS focused on improving health in old age.

Find out more (University of Oxford website)

Similar stories

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.

Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells

Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.

Daily contact COVID-19 testing for students effective at controlling transmission in schools

A study by the University of Oxford has found that daily testing of secondary school students who were in contact with someone with COVID-19 was just as effective in controlling school transmission as the current 10-day contact isolation policy.